Learn more about the use of mHealth technology
in the mental health space
Peter Hagelund beskriver, hvordan brugen af Monsenso mHealth løsning kunne have hjulpet ham og hans psykiater med at diagnosticere hans bipolare lidelse type 2 tidligere, og derved reddet ham fra måneder med angst og forvirring.
Peter Hagelund discusses how Monsenso’s mHealth solution has helped his psychiatrist diagnose his Bipolar Disorder Type 2 more quickly and accurately, helping him avoid further months of anxiety and confusion.
Swedish Psychiatrist Kristoffer Södersten shares his experience using the Monsenso clinic to help treat his clients, and talks about how mobile health has helped him improve delivering psychiatric treatment.
In 1998, the Quality Chasm series was launched by the Institute of Medicine which included an informative report about delivering high quality healthcare. The report was entitled “Crossing the Quality Chasm: A New Health System for the 21st Century”.The strategies...
Big data can transform the mental health and life science industry. CPO Mads Frost writes a guest blog about how Monsenso’s mHealth solution offers new ways to inform treatment.
Mhealth can improve health outcomes by helping clinicians collect, view, and analyse patient information more efficiently.
Lack of budget and aversion to technology can make mHealth seem like an undesirable choice. We explored how our mHealth solution can help debunk these myths and avoid these obstacles.
Telehealth for mental healthcare makes a lot of sense since mental health care is generally harder to access than other health services, due to a shortage of qualified mental health providers and coverage limits.
mHealth provides the opportunity to offer scalable and cost-effective mental healthcare. One of the greatest challenges the healthcare systems face is the long-term care of individuals with severe mental disorders. Fortunately, some of these issues can be partially solved with the use of mHealth technology.
Pharma can benefit from mHealth solutions by using them in clinical trials and by offering them to HCPs as part of a comprehensive treatment solution.